Corpus Intelligence IC Memo — CHANGEPOINT PSYCHIARIC HOSPITAL 2026-04-26 14:10 UTC
IC Memo — CHANGEPOINT PSYCHIARIC HOSPITAL
Investment Committee Memorandum | AZ | 16 beds | Grade D | EBITDA uplift $432K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHANGEPOINT PSYCHIARIC HOSPITAL

CCN 034027 | NAVAJO, AZ | 16 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CHANGEPOINT PSYCHIARIC HOSPITAL is a 16-bed safety-net/medicaid heavy in NAVAJO, AZ with $5.7M in net patient revenue and a -23.0% operating margin. The hospital serves a payer mix of 1.2% Medicare, 81.8% Medicaid, and 16.9% commercial.

Thesis: Turnaround. Our ML models identify $432K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.0% to -15.5% (+755bps).

Net Revenue HCRIS$5.7M
Current EBITDA COMPUTED$-1.3M
Operating Margin COMPUTED-23.0%
Occupancy HCRIS94.6%
Revenue / Bed COMPUTED$357K
Net-to-Gross HCRIS88.8%
Distress Probability ML63.2%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
29
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -23.0% places it below the state median. Among 29 size-comparable peers (8-32 beds), the median margin is -3.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 29 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHANGEPOINT PSYCHIARIC HOSPITA (Target)AZ16$5.7M-23.0%
ARIZONA GENERAL HOSPITALAZ16$97.1M10.4%
THE CORE INSTITUTE SPECIALTY HAZ28$91.2M9.2%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$75.2M-2.8%
COBRE VALLEY REG. MEDICAL CENTAZ25$74.9M-10.3%
COPPER QUEEN COMM. HOSP.AZ14$63.5M6.6%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$49.4M-6.8%
BANNER PAYSON MEDICAL CENTERAZ25$49.3M0.0%
AZ SPINE & JOINT HOSPITALAZ23$45.1M19.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $432K (755bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$120K+210bp18mo
Denial Rate Reduction12.0%6.5%$118K+207bp12mo
Cost to Collect4.5%2.5%$114K+200bp12mo
A/R Days Reduction5200.0%3800.0%$70K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+17bp6mo

5. EBITDA Bridge

Net Collection Rate
$120K
Denial Rate Reduction
$118K
Cost to Collect
$114K
A/R Days Reduction
$70K
Clean Claim Rate
$10K
Total EBITDA Uplift$432K
Current EBITDA$-1.3M
+ RCM Uplift+$432K
Pro Forma EBITDA$-884K
Current Margin-23.0%
Pro Forma Margin-15.5%
WC Released (1x)$219K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.0M$-4.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.0M$-5.5M0.00x-100.0%
Bull Case9.0x11.0x$-1.8M$-4.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.8M$-5.7M0.00x-100.0%
Bear Case11.0x10.0x$-2.2M$-5.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.2M$-7.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (81.8%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 63.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 29 hospitals with 8-32 beds
  • Same-state prioritization (n=31)
  • Comp margins: P25=-10.1% / P50=-3.1% / P75=7.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.